Back to Search
Start Over
Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication
- Source :
- Journal of Clinical Investigation. June 1, 2014, Vol. 124 Issue 6, p2802, 5 p.
- Publication Year :
- 2014
-
Abstract
- Damage to the intestinal mucosa results in the translocation of microbes from the intestinal lumen into the circulation. Microbial translocation has been proposed to trigger immune activation, inflammation, and coagulopathy, all of which are key factors that drive HIV disease progression and non-HIV comorbidities; however, direct proof of a causal link is still lacking. Here, we have demonstrated that treatment of acutely SIV-infected pigtailed macaques with the drug sevelamer, which binds microbial lipopolysaccharide in the gut, dramatically reduces immune activation and inflammation and slightly reduces viral replication. Furthermore, sevelamer administration reduced coagulation biomarkers, confirming the contribution of microbial translocation in the development of cardiovascular comorbidities in SIV-infected nonhuman primates. Together, our data suggest that early control of microbial translocation may improve the outcome of HIV infection and limit noninfectious comorbidities associated with AIDS.<br />Introduction The current paradigm of HIV/SIV pathogenesis is that chronic immune activation and inflammation are major determinants of disease progression to AIDS, independent of viral replication or [CD4.sup.+] T cell [...]
Details
- Language :
- English
- ISSN :
- 00219738
- Volume :
- 124
- Issue :
- 6
- Database :
- Gale General OneFile
- Journal :
- Journal of Clinical Investigation
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.372250865
- Full Text :
- https://doi.org/10.1172/JCI75090